Alvotech is a global biotech company focused solely on the development and manufacture of biosimilar medicines for patients worldwide. Alvotech is listed on Nasdaq Global Market in the U.S. and on Nasdaq Iceland Main Market in Iceland. On May 8 2025, Alvotech announced its intention to list Swedish Depository Receipts (SDRs) on Nasdaq Stockholm. This webpage contains the prospectus and other relevant information related to the listing:

Project Asgard - Prospectus launch_vS.pdf

Project Asgard - Prospectus - Final version.pdf

SDR Conversion - Informative letter and application.pdf

Prospectus published: May 8, 2025
Application period: May 9-16, 2025
First day of trading: May 19, 2025
Settlement date: May 21, 2025

Benedikt Stefansson, VP Investor Relations and Global Communications
alvotech.ir@alvotech.com

Alvotech är ett globalt biofarmaceutiskt företag som specialiserar sig på utveckling och tillverkning av biosimilarer. Alvotech är noterat på Nasdaq Global Market i USA och på Nasdaq Iceland Main Market på Island. Den 8 maj 2025 offentliggjorde Alvotech sin intention att genomföra en notering av svenska depåbevis (SDB:er) på Nasdaq Stockholm. På denna ebbsida finns prospektet tillgängligt samt annan relevant information relaterat till noteringen:

Prospektpublicering: 8 maj 2025
Anmälningsperiod: 9 maj 2025 - 16 maj 2025
Första handelsdag: 19 maj 2025
Likviddag: 21 maj 2025

Stockholm listing

Due to restrictions under applicable securities laws, the information contained herein is not for release, publication or distribution, directly or indirectly, in whole or in part, to persons resident or physically present outside of Sweden. We apologize for any inconvenience this may cause.
Click here to return to the homepage

The information contained on the following web pages relates to a proposed offer and issue by Alvotech S.A. solely directed to the public in Sweden. Due to restrictions under applicable securities laws, including the U.S Securities Act of 1933, as amended, the information contained herein is not for release, publication or distribution, in whole or in part, outside of Sweden, and may not be accessed by persons other than residents of Sweden that are located in Sweden.

The information contained in this section of our website relates to the offering of Swedish depositary receipts (“SDRs”) to the public in Sweden (the “Offering”) and the listing of the SDRs on Nasdaq Stockholm. Due to restrictions under applicable securities laws, including the U.S. Securities Act of 1933, as amended, the information contained herein is not for release, publication or distribution, directly or indirectly, in whole or in part, to persons resident or physically present outside of Sweden. The information contained in this section of our website does not constitute an offer to sell, or a solicitation of an offer to purchase, any securities in any jurisdictions other than Sweden.

The SDRs, the shares underlying the SDRs, or any other securities the Company may offer in the Offering (the “Securities”), have not been and will not be registered under the United States Securities Act of 1933, as amended (the “Securities Act”), or the securities legislation of any other state or other jurisdiction in the United States, and are being offered and sold in reliance on Regulation S promulgated under the Securities Act (“Regulation S”) in accordance with the local laws and customary practices and documentation of Sweden and solely directed to the public in Sweden. The Securities may not be offered, sold or otherwise transferred, directly or indirectly, in or into the United States except under an available exemption from, or by a transaction not subject to, the registration requirements under the Securities Act and in compliance with the securities legislation in the relevant state or any other jurisdiction of the United States. No public offering of the Securities is being made in the United States or any country other than Sweden.

The Company assumes no responsibility if there is a violation of applicable law and regulations by any person.

If you are not a resident of Sweden and located in Sweden, please exit this website.

In order to be eligible to view the information on this website, you shall confirm and acknowledge that:

you are not a “U.S. person” (as defined in Regulation S);

you were outside of the United States at the time you first expressed an interest in acquiring the SDRs and are currently outside of the United States;

you are not an affiliate of the Company (as defined in Rule 144 under the Securities Act);

you are acquiring the Securities in this Offering for your own account in the ordinary course of business and have no direct or indirect arrangements or understandings with any other persons to distribute or regarding the distribution of the Securities;

you will not transmit or broadcast information from this website to publications distributed in the United States; and

you have read, and you accept as binding on you, the information as well as the terms and conditions contained on this page.

Important information